Amulet Capital Appoints Michael Keaveney Head of Investor Relations

Experienced Industry Executive to Lead Capital Raising and Investor Engagement Efforts

GREENWICH, Conn. & WALNUT CREEK, Calif.--()--Amulet Capital Partners, LP (“Amulet”), a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced that Michael Keaveney has joined the firm as a Partner and Head of Investor Relations. Mr. Keaveney will oversee the firm’s capital formation, fundraising and investor engagement initiatives, and will work closely with the firm’s leadership team and investment committee to grow the firm’s diversified investor base around the world.

Mr. Keaveney joins Amulet with nearly 20 years of fundraising and investor relations experience. He most recently served as a Partner at Capstone Partners, a leading placement agent providing global fundraising and advisory services to private equity, credit, real assets and infrastructure firms. At Capstone, he was responsible for distribution and business development in the Northeast and Eastern United States. Prior to his more than 10-year tenure at Capstone, Mr. Keaveney worked at Mercury Capital Advisors, a global private equity placement and investment advisory firm. Mr. Keaveney also held positions at Atlantic Pacific Capital and Performance Equity Management after starting his career in investment banking at Credit Suisse.

“Following the recent close of our oversubscribed third fund, we are pleased to welcome an executive of Michael’s caliber to our team to lead our investor-focused efforts,” said Ramsey Frank, President and Managing Partner at Amulet. “His deep capital raising experience and familiarity with the Amulet platform will significantly benefit our investors as we continue to grow and deliver compelling, thematic-driven investment opportunities within the healthcare landscape.”

“I have had the pleasure of working alongside the Amulet team for many years during my time at Capstone, and have always had deep respect for what the team has accomplished and the strength of the platform they’ve built,” said Mr. Keaveney. “At a time when there is a growing need for increased investment across the healthcare system, I look forward to working closely with Ramsey, Jay and the exceptional Amulet team to grow the firm’s investor relationships and capital formation efforts.”

“Michael has served as a trusted advisor to our team throughout multiple capital raising cycles, and he shares our commitment to creating value for our investors and portfolio companies, while improving outcomes for patients,” said Jay Rose, Managing Partner at Amulet. “As we continue to grow as a firm, Michael’s expertise and deep network of relationships will help us better support our limited partners and grow our global base of valued investors.”

About Amulet Capital Partners

Amulet Capital Partners is a middle-market private equity investment firm based in Greenwich, CT, and Walnut Creek, CA, focused exclusively on the healthcare sector. Amulet seeks to achieve long-term capital appreciation through privately negotiated investments in healthcare companies. Amulet focuses on those segments it believes have the most attractive long-term fundamentals with a target investment size between $50 million to $150 million. For additional information, please visit www.amuletcapital.com.

Contacts

Media
Erik Carlson / Madeline Jones
Joele Frank, Wilkinson Brimmer Katcher
(212) 355-4449

Contacts

Media
Erik Carlson / Madeline Jones
Joele Frank, Wilkinson Brimmer Katcher
(212) 355-4449